Role of the renal biopsy in acute renal failure

Contributions to Nephrology

Volumn 132, Issue , 2001, Pages 68-75

  Solez, Kim ^a   Racusen, Lorraine C ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; BIOPSY; HUMAN; KIDNEY; KIDNEY TUBULE NECROSIS; PATHOLOGY; REVIEW;

BIOPSY; HUMANS; KIDNEY; KIDNEY FAILURE, ACUTE; KIDNEY TUBULAR NECROSIS, ACUTE;

EID: 0035532665     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000060082     Document Type: Article

References (26)

1. Star R: Design issues for clinical trials in acute renal failure. Blood Purif 2001;19:233-237.
2. Star RA: Treatment of acute renal failure. Kidney Int 1998;54:1817-1831.
3. http://navigators.com/statmae.gif
4. Shaw S, Weidmann P, Zimmermann A: Urodilatin, not nitroprusside, combined with dopamine reverses ischemic acute renal failure. Kidney Int 1992;42:1153-1159.
5. Gellai M, Jugus M, Fletcher T, Nambi P, Ohlstein EH, Elliott JD, Brooks DP: Nonpeptide endothelin receptor antagonists. V. Prevention and reversal of acute renal failure in the rat by SB 209670. J Pharmacol Exp Ther 1995;275:200-206.
6. Gellai M, Jugus M, Fletcher T, DeWolf R, Nambi P: Reversal of postischemic acute renal failure with a selective endothelin A receptor antagonist in the rat. J Clin Invest 1994;93:900-906.
7. Chiao H, Kohda Y, McLeroy P, Craig L, Housini I, Star RA: Alpha-melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats. J Clin Invest 1997;99:1165-1172.
8. Chiao H, Kohda Y, McLeroy P, Craig L, Linas S, Star RA: Alpha-melanocyte-stimulating hormone inhibits renal injury in the absence of neutrophils. Kidney Int 1998;54:765-774.
9. Lewis J, Salem MM, Chertow GM, Weisberg LS, McGrew F, Marbury TC, Allgren RL: Atrial natriuretic factor in oliguric acute renal failure. Anaritide Acute Renal Failure Study Group. Am J Kidney Dis 2000;36:767-774.
10. Ricksten SE: Lower dose and longer duration of administration of atrial natriuretic peptide in acute renal failure. Am J Kidney Dis 2001;37:454-455.
11. Allgren RL, Marbury TC, Rahman SN, Weisberg LS, Fenves AZ, Lafayette RA, Sweet RM, Genter FC, Kurnik BR, Conger JD, Sayegh MH: Anaritide in acute tubular necrosis. Auriculin Anaritide Acute Renal Failure Study Group. N Engl J Med 1997;336:828-834.
12. Hirschberg R, Kopple J, Lipsett P, Benjamin E, Minei J, Albertson T, Munger M, Metzler M, Zaloga G, Murray M, Lowry S, Conger J, McKeown W, O'Shea M, Baughman R, Wood K, Haupt M, Kaiser R, Simms H, Warnock D, Summer W, Hintz R, Myers B, Haenftling K: Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure. Kidney Int 1999;55:2423-2432.
13. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G: Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: A prospective randomized trial. Lancet 2000;356:26-30.
14. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W: Prevention of radiographiccontrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000; 343:180-184.
15. Solez K, Morel-Maroger L, Sraer JD: The morphology of 'acute tubular necrosis' in man: Analysis of 57 renal biopsies and a comparison with the glycerol model. Medicine (Baltimore) 1979;58: 362-376.
16. Solez K, Whelton A (eds): Acute Renal Failure: Correlations between Morphology and Function. New York, Dekker, 1984, pp 1-512.
17. Simckes AM, Blowey DL, Gyves KM, Alon US: Success and safety of same-day kidney biopsy in children and adolescents. Pediatr Nephrol 2000;14:946-952.
18. Nass K, O'Neill WC: Bedside renal biopsy: Ultrasound guidance by the nephrologist. Am J Kidney Dis 1999;34:955-959.
19. Cameron JS: Indications for renal biopsy, history of the procedure, and relationship of findings to further investigation and treatment; in Solez K, Racusen LC, Olsen S (eds): Diagnostic Renal Pathology. New York, McGraw-Hill, 2001. See also: http://www.transpath.com/m-media/ DRP.htm
20. Hsiao LL, Stears RL, Hong RL, Gullans SR: Prospective use of DANN microarrays for evaluating renal function and disease. Curr Opin Nephrol Hypertens 2000;9:253-258. See also: http:// www.gene-chips.com and http://www.devicelink.com/ivdt/archive/98/09/009.html
21. Racusen LC, Fivush BA, Li YL, Slatnik I, Solez K: Dissociation of tubular cell detachment and tubular cell death in clinical and experimental 'acute tubular necrosis'. Lab Invest 1991;64:546-556.
22. Racusen LC: Pathology of acute renal failure: Structure/function correlations. Adv Ren Replace Ther 1997;4(suppl 1):3-16.
23. Racusen LC: The histopathology of acute renal failure. New Horiz 1995;3:662-668.
24. Solez K, Racusen LC, Marcussen N, Slatnik I, Keown P, Burdick JF, Olsen S: Morphology of ischemic acute renal failure, normal function, and cyclosporine toxicity in cyclosporine-treated renal allograft recipients. Kidney Int 1993;43:1058-1067.
25. Corrigan G, Ramaswamy D, Kwon O, Sommer FG, Alfrey EJ, Dafoe DC, Olshen RA, Scandling JD, Myers BD: PAH extraction and estimation of plasma flow in human postischemic acute renal failure. Am J Physiol 1999;277:F312-F318.
26. Anderson RJ: Progress in understanding human ischemic acute renal failure. Am J Kidney Dis 2001;37:438-441.